1. Medtech Insight
  2. >>Archive

Siemens and BrainLab introduce NaviVision surgical navigation platform:

Siemens Medical Solutions and image-guided therapy developer BrainLAB have introduced a surgical technology platform to allow doctors more room in the operating room and help facilitate workflow. The NaviVision system, due for commercial launch in January 2006, combines Siemens' surgical C-arm with BrainLAB's optical 2D/3D navigation unit. NaviVision is the first integrated optical navigation platform to feature automatic recording for surgery supported by an image receptor, the companies said. The system's navigation can be attached directly to the C-arm's workstation or directly to the OR table. Using a touch screen, the surgeon can easily operate the system's monitor and switch between axial and lateral views. The system was introduced as a "work-in-progress" at last month's annual meeting of the Radiological Society of North America (RSNA).

Siemens Medical Solutions and image-guided therapy developer BrainLAB have introduced a surgical technology platform to allow doctors more room in the operating room and help facilitate workflow. The NaviVision system, due for commercial launch in January 2006, combines Siemens' surgical C-arm with BrainLAB's optical 2D/3D navigation unit. NaviVision is the first integrated optical navigation platform to feature automatic recording for surgery supported by an image receptor, the companies said. The system's navigation can be attached directly to the C-arm's workstation or directly to the OR table. Using a touch screen, the surgeon can easily operate the system's monitor and switch between axial and lateral views. The system was introduced as a "work-in-progress" at last month's annual meeting of the Radiological Society of North America (RSNA).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By Ryan Nelson

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By Marion Webb

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 
• By Natasha Barrow

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Veterinary Heart Health Goes High-Tech: Eko And Boehringer Use AI To Spot Heart Murmurs In Dogs

 
• By Marion Webb

Eko hopes its new partnership with Boehringer Ingelheim to develop algorithms for accurately detecting heart murmurs in dogs will pave the way for more collaborations with medical and pharmaceutical companies to advance early detection in humans as well as animals.

Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist

 
• By Natasha Barrow

Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.

Increasing Safety Concerns Spur Scrutiny of Device Plastics Use

 
• By Elizabeth Orr

With new regulations limiting the use of plastics popping up worldwide, the medtech industry sees arguments on both sides. Some argue hasty bans of PFAS ("forever chemicals") would harm patients, while others say phthalates should be phased out to protect the public.